Response, Survival, and Prognostic Factors After Hepatic Arterial Chemoembolization in Patients With Liver Metastases From Cutaneous Melanoma

REFERENCES

• Hall HI, Miller DR, Rogers JD, Bewerse B. Update on the incidence and mortality from melanoma in the United States. J Am Acad Dermatol 1999;40:35–42.
   PubMed Web of Science ®Google Scholar
• Jemal A, Devesa SS, Hartge P, Tucker MA. Recent trends in cutaneous melanoma incidence among whites in the United States. J Natl Cancer Inst 2001;93:678–683.
   PubMed Web of Science ®Google Scholar
• Linos E, Swetter SM, Cockburn MG, Colditz GA, Clarke CA. Increasing burden of melanoma in the United States. J Invest Dermatol 2009;129:1666–1674.
   PubMed Web of Science ®Google Scholar
• Becker JC, Terheyden P, Kämpgen E, Wagner S, Neumann C, Schadendorf D, Steinmann A, Wittenberg G, Lieb W, Bröcker EB. Treatment of disseminated ocular melanoma with sequential fotemustine, interferon alpha, and interleukin 2. Br J Cancer 2002;87:840–845.
   PubMed Web of Science ®Google Scholar
• Leiter U, Meier F, Schittek B, Garbe C. The natural course of cutaneous melanoma. J Surg Oncol 2004;86:172–178.
   PubMed Web of Science ®Google Scholar
• Feldman ED, Pingpank JF, Alexander HR Jr. Regional treatment options for patients with ocular melanoma metastatic to the liver. Ann Surg Oncol 2004;11:290–297.
   PubMed Web of Science ®Google Scholar
• Gragoudas ES, Egan KM, Seddon JM, Glynn RJ, Walsh SM, Finn SM, Munzenrider JE, Spar MD. Survival of patients with metastases from uveal melanoma. Ophthalmology 1991;98:383–389; discussion 390.
   PubMed Web of Science ®Google Scholar
• Pyrhonen S. The treatment of metastatic uveal melanoma. Eur J Cancer 1998;34(Suppl. 3):S27–S30.
   PubMedGoogle Scholar
• Francken AB, Accortt NA, Shaw HM, et al. Prognosis and determinants of outcome following locoregional or distant recurrence in patients with cutaneous melanoma. Ann Surg Oncol 2008;15:1476–1484.
   PubMed Web of Science ®Google Scholar
• Barth A, Wanek LA, Morton DL. Prognostic factors in 1,521 melanoma patients with distant metastases. J Am Coll Surg 1995; 181:193–201.
   PubMed Web of Science ®Google Scholar
• Agarwala SS, Panikkar R, Kirkwood JM. Phase I/II randomized trial of intrahepatic arterial infusion chemotherapy with cisplatin and chemoembolization with cisplatin and polyvinyl sponge in patients with ocular melanoma metastatic to the liver. Melanoma Res 2004;14:217–222.
   PubMed Web of Science ®Google Scholar
• Bedikian AY, Legha SS, Mavligit G, Carrasco CH, Khorana S, Plager C, Papadopoulos N, Benjamin RS. Treatment of uveal melanoma metastatic to the liver: a review of the M. D. Anderson Cancer Center experience and prognostic factors. Cancer 1995;76:1665–1670.
   PubMed Web of Science ®Google Scholar
• Carrasco CH, Wallace S, Charnsangavej C, Papadopoulos NE, Patt YZ, Mavligit GM. Treatment of hepatic metastases in ocular melanoma. Embolization of the hepatic artery with polyvinyl sponge and cisplatin. JAMA 1986;255:3152–3154.
   PubMed Web of Science ®Google Scholar
• Patel K, Sullivan K, Berd D, Mastrangelo MJ, Shields CL, Shields JA, Sato T. Chemoembolization of the hepatic artery with BCNU for metastatic uveal melanoma: results of a phase II study. Melanoma Res 2005;15:297–304.
   PubMed Web of Science ®Google Scholar
• Sharma KV, Gould JE, Harbour JW, Linette GP, Pilgram TK, Dayani PN, Brown DB. Hepatic arterial chemoembolization for management of metastatic melanoma. AJR Am J Roentgenol 2008;190:99–104.
   PubMed Web of Science ®Google Scholar
• Vogl T, Eichler K, Zangos S, Herzog C, Hammerstingl R, Balzer J, Gholami A. Preliminary experience with transarterial chemoembolization (TACE) in liver metastases of uveal malignant melanoma: local tumor control and survival. J Cancer Res Clin Oncol 2007;133:177–184.
   PubMed Web of Science ®Google Scholar
• Mavligit GM, Charnsangavej C, Carrasco CH, Patt YZ, Benjamin RS, Wallace S. Regression of ocular melanoma metastatic to the liver after hepatic arterial chemoembolization with cisplatin and polyvinyl sponge. JAMA 1988;260:974–976.
   PubMed Web of Science ®Google Scholar
• Rajpal S, Moore R, Karakousis CP. Survival in metastatic ocular melanoma. Cancer 1983;52:334–336.
   PubMed Web of Science ®Google Scholar
• Siegel R, Hauschild A, Kettelhack C, Kahler KC, Bembenek A, Schlag PM. Hepatic arterial Fotemustine chemotherapy in patients with liver metastases from cutaneous melanoma is as effective as in ocular melanoma. Eur J Surg Oncol 2007;33:627–632.
   PubMed Web of Science ®Google Scholar
• Gupta S, Bedikian AY, Ahrar J, Ensor J, Ahrar K, Madoff DC, Wallace MJ, Murthy R, Tam A, Hwu P. Hepatic artery chemoembolization in patients with ocular melanoma metastatic to the liver: response, survival, and prognostic factors. Am J Clin Oncol 2009.
   PubMedGoogle Scholar
• Leyvraz S, Spataro V, Bauer J, Pampallona S, Salmon R, Dorval T, Meuli R, Gillet M, Lejeune F, Zografos L. Treatment of ocular melanoma metastatic to the liver by hepatic arterial chemotherapy. J Clin Oncol 1997;15:2589–2595.
   PubMed Web of Science ®Google Scholar
• Balch CM, Soong SJ, Murad TM, Smith JW, Maddox WA, Durant JR. A multifactorial analysis of melanoma. IV. Prognostic factors in 200 melanoma patients with distant metastases (stage III). J Clin Oncol 1983;1:126–134.
   PubMed Web of Science ®Google Scholar
• Meyer T, Merkel S, Goehl J, Hohenberger W. Surgical therapy for distant metastases of malignant melanoma. Cancer 2000;89:1983–1991.
   PubMed Web of Science ®Google Scholar
• Kolmel KF, Kulle B, Lippold A, Seebacher C. Survival probabilities and hazard functions of malignant melanoma in Germany 1972–1996, an analysis of 10433 patients. Evolution of gender differences and malignancy. Eur J Cancer 2002;38:1388–1394.
   PubMed Web of Science ®Google Scholar
• Masback A, Olsson H, Westerdahl J, Ingvar C, Jonsson N. Prognostic factors in invasive cutaneous malignant melanoma: a population-based study and review. Melanoma Res 2001;11: 435–445.
   PubMed Web of Science ®Google Scholar
• Schmoeckel C, Braun-Falco O. Prognostic index in malignant melanoma. Arch Dermatol 1978;114:871–873.
   PubMed Web of Science ®Google Scholar
• Ahmed I. Malignant melanoma: prognostic indicators. Mayo Clin Proc 1997;72:356–361.
   PubMed Web of Science ®Google Scholar
• Gupta S, Johnson MM, Murthy R, Ahrar K, Wallace MJ, Madoff DC, McRae SE, Hicks ME, Rao S, Vauthey JN, Ajani JA, Yao JC. Hepatic arterial embolization and chemoembolization for the treatment of patients with metastatic neuroendocrine tumors: variables affecting response rates and survival. Cancer 2005;104: 1590–1602.
   PubMed Web of Science ®Google Scholar
• Kobayashi K, Gupta S, Trent JC, Vauthey JN, Krishnamurthy S, Ensor J, Ahrar K, Wallace MJ, Madoff DC, Murthy R, McRae SE, Hicks ME. Hepatic artery chemoembolization for 110 gastrointestinal stromal tumors: response, survival, and prognostic factors. Cancer 2006;107:2833–2841.
   PubMed Web of Science ®Google Scholar
• Yamashita Y, Takahashi M, Koga Y, Saito R, Nanakawa S, Hatanaka Y, Sato N, Nakashima K, Urata J, Yoshizumi K, Ito K, Sumi S. Prognostic factors in liver metastases after transcatheter arterial embolization or arterial infusion. Acta Radiol 1990;31:269–274.
   PubMed Web of Science ®Google Scholar